Beta-blocker use and COPD mortality: a systematic review and meta-analysis

Statin use in COPD patients is associated with a reduction in mortality: a national cohort study

(2012) Carlene MM Lawes et al.   Primary Care Respiratory Journal

2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

(2011) Jeffrey L. Anderson et al.   CIRCULATION

β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease

(2010) Frans H. Rutten   ARCHIVES OF INTERNAL MEDICINE

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)

(2009) Nathaniel M. Hawkins et al.   EUROPEAN JOURNAL OF HEART FAILURE

Immeasurable Time Bias in Observational Studies of Drug Effects on Mortality

(2008) S. Suissa   AMERICAN JOURNAL OF EPIDEMIOLOGY

Impact of Cardioselective β-Blockers on Mortality in Patients with Chronic Obstructive Pulmonary Disease and Atherosclerosis

(2008) Yvette R. B. M. van Gestel et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Use of   blockers and the risk of death in hospitalised patients with acute exacerbations of COPD

(2007) M T Dransfield et al.   THORAX